US 7163934
Methods for treating delirium glucocorticoid receptor-specific antagonists
granted A61KA61K31/47A61K31/573
Quick answer
US patent 7163934 (Methods for treating delirium glucocorticoid receptor-specific antagonists) held by Corcept Therapeutics Incorporated expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/47, A61K31/573